PMID- 19949672 OWN - NLM STAT- MEDLINE DCOM- 20100127 LR - 20211020 IS - 1598-6357 (Electronic) IS - 1011-8934 (Print) IS - 1011-8934 (Linking) VI - 24 IP - 6 DP - 2009 Dec TI - The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice. PG - 1139-44 LID - 10.3346/jkms.2009.24.6.1139 [doi] AB - To evaluate the ability of fluorescence in situ hybridization (FISH) in detecting bladder urothelial carcinoma (BUC), FISH and cytology were compared for the evaluation of 308 consecutive urine samples from patients suspected of having BUC. All patients underwent cystoscopy for identification of bladder lesions. The FISH results were compared with the cytology assessment. In all, 122 patients had confirmed BUC. Among them, 68 (55.7%) were FISH-positive, while only 33 (27%) were positive on cytology. According to disease stage (superficial vs. invasive) and grade (low vs. high), the sensitivities of FISH were also significantly higher than those of cytology in all categories. Moreover, in 36 patients who had no visible tumor with flat, erythematous mucosa (suspicious lesion), FISH was more sensitive than cytology for the detection of BUC (83.3% vs. 33.3%, P=0.002). The FISH was negative in 168 (90.3%) of 186 patients with no histological evidence of BUC or negative cystoscopy findings. The sensitivity of FISH for detecting BUC was superior to that of cytology, regardless of tumor stage and grade. FISH is a significant additional and complementary method for detection of BUC in patients who have suspicious lesions on cystoscopy. FAU - Kwak, Kyung Won AU - Kwak KW AD - Department of Urology, KEPCO (Korea Electric Power Corporation) Medical Foundation, Hanil General Hospital, Seoul, Korea. FAU - Kim, Sun Hee AU - Kim SH FAU - Lee, Hyun Moo AU - Lee HM LA - eng PT - Journal Article DEP - 20091109 PL - Korea (South) TA - J Korean Med Sci JT - Journal of Korean medical science JID - 8703518 SB - IM MH - Aged MH - Carcinoma, Transitional Cell/diagnosis/*pathology MH - Female MH - Humans MH - *In Situ Hybridization, Fluorescence/methods MH - Male MH - Middle Aged MH - Reproducibility of Results MH - Sensitivity and Specificity MH - Urinary Bladder Neoplasms/*diagnosis/pathology MH - Urine/cytology MH - Urothelium/*pathology PMC - PMC2775864 OTO - NOTNLM OT - Bladder Urothelial Carcinoma OT - Cytology OT - In Situ Hybridization, Fluorescence EDAT- 2009/12/02 06:00 MHDA- 2010/01/28 06:00 PMCR- 2009/12/01 CRDT- 2009/12/02 06:00 PHST- 2008/12/04 00:00 [received] PHST- 2009/01/20 00:00 [accepted] PHST- 2009/12/02 06:00 [entrez] PHST- 2009/12/02 06:00 [pubmed] PHST- 2010/01/28 06:00 [medline] PHST- 2009/12/01 00:00 [pmc-release] AID - 10.3346/jkms.2009.24.6.1139 [doi] PST - ppublish SO - J Korean Med Sci. 2009 Dec;24(6):1139-44. doi: 10.3346/jkms.2009.24.6.1139. Epub 2009 Nov 9.